• 1
    McCuskey RS. Hepatic microvascular response to endotoxemia and sepsis. In: MessmerK, MengerMD, eds. Progress in Applied Microcirculation. Basel: Karger, 1993; 19: 7684.
  • 2
    Vollmar B, Rüttinger D, Wanner GA, Leiderer R, Menger MD. Modulation of Kupffer cell activity by gadolinium chloride in endotoxemic rats. Shock 1996; 6: 434441.
  • 3
    Chensue SW, Terebuh PD, Remick DG, Scales WE, Kunkel SL. In vivo biologic and immunohistochemical analysis of interleukin-1 alpha, beta and tumor necrosis factor during experimental endotoxemia. Kinetics, Kupffer cell expression, and glucocorticoid effects. Am J Pathol 1991; 138: 395402.
  • 4
    Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. Endotoxin-induced cytokine gene expression and excretion in the liver. HEPATOLOGY 1994; 19: 480488.
  • 5
    Matsumoto Y, Ito Y, Hayashi I, Majima M, Ishii K, Katagiri H, Kakita A. Effect of FR167653, a novel inhibitor of tumor necrosis factor alpha and interleukin-1 beta synthesis on lipopolysaccharide-induced hepatic microvascular dysfunction in mice. Shock 2002; 17: 411415.
  • 6
    Decker K. Biologically active products of stimulated liver macrophages. Eur J Biochem 1990; 192: 245361.
  • 7
    Altavilla D Squadrito F, Canale P, Ioculano M, Squadrito G, Campo GM, Serrano M, et al. G619, a dual thromboxane synthase inhibitor and thromboxane A2 receptor antagonist, inhibits tumor necrosis factor-α biosynthesis. Eur J Pharmacol 1995; 286: 3139.
  • 8
    Ishiguro S, Arii S, Monden K, Adachi Y, Funaki N, Higashitsuji H, Fujita S, et al. Identification of the thromboxane A2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats. HEPATOLOGY 1994; 20: 12811286.
  • 9
    Karck U, Peters T, Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 1988; 7: 352361.
  • 10
    Otto JC, Smith WL. Prostaglandin endoperoxide synthases-1 and -2. J Lipid Mediat Cell Signal 1995; 12: 139156.
  • 11
    Ruetten H, Thiemermann C. Effect of calpain inhibitor I, an inhibitor of the proteolysis of IκB, on the circulatory failure and multiple organ dysfunction caused by endotoxin in the rat. Br J Pharmacol 1997; 121: 695704.
  • 12
    Dinchuk JR, Car BD, Focht RJ, Johnson JJ, Jaffee BD, Covington MB, Contel NR, et al. Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 1995; 378: 406409.
  • 13
    Sunose Y, Takeyoshi I, Ohwada S, Tsutsumi H, Iwazaki S, Kawata K, Kawashima Y, et al. The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J Am Coll Surg 2001; 192: 5462.
  • 14
    Hanasaki K, Nagasaki T, Arita H. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145. Biochem Pharmacol 1989; 38: 20072017.
  • 15
    Smith CJ, Zhang Y, Koboldt CM, Muhammad J, Zweifel BS, Shaffer A, Talley JJ, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A 1998; 95: 1331313318.
  • 16
    Futaki N, Yoshikawa K, Hamasuka Y, Arai I, Higuchi S, Iizuka H, Otomo S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen Pharmacol 1993; 24: 105110.
  • 17
    Xiao CY, Hara A, Yuhki K, Fujino T, Ma H, Okada Y, Takahata O, et al. Roles of prostaglandin I2 and thromboxane A2 in cardiac ischemia-reperfusion injury. Circulation 2001; 104: 22102205.
  • 18
    Post S, Palma P, Rentsch M, Gonzalez MD, Menger MD. Hepatic reperfusion injury following cold ischemia in the rat: potentials and quantitative analysis by in vivo fluorescence microscopy. In: MessmerK, MengerMD, eds. Progress in Applied Microcirculation. Basel: Karger, 1993; 19: 152166.
  • 19
    Suematsu M, Goda N, Sano T, Kashiwagi S, Shinoda Y, Ishimura Y. Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. J Clin Invest 1995; 96: 24312437.
  • 20
    Suzuki Y, Ueno A, Kawamura M, Nishiyama K, Katori M, Okabe H. Prostaglandin levels in the rat resting gastric wall and enhancement of prostaglandin E2 generation after administration of mild hyperosmotic saline solution into the gastric lumen. Eicosanoids 1990; 3: 2327.
  • 21
    Boku K, Ohno T, Saeki T, Hayashi H, Hayashi I, Katori M, Murata T, et al. Adaptive cytoprotection mediated by prostaglandin I2 is attributable to sensitization of CGRP-containing sensory nerves. Gastroenterology 2001; 120: 134143.
  • 22
    Majima M, Isono M, Ikeda Y, Hayashi I, Hatanaka K, Harada Y, Katsumata O, et al. Significant roles of inducible cyclooxygenase (COX)-2 in angiogenesis in rat sponge implants. Jpn J Pharmacol 1997; 75: 105114.
  • 23
    Molle WV, Berghe JV, Brouchaert P, Libert C. Tumor necrosis factor-α-induced lethal hepatitis: pharmacological intervention with verapamil, tannic acid, picotamide and K76COOH. FEBS Lett 2000; 467: 201205.
  • 24
    Shirabe K, Kin S, Shinagawa Y, Chen S, Payne WD, Sugimachi K. Inhibition of thromboxane A2 activity during warm ischemia of the liver. J Surg Res 1996; 61: 103107.
  • 25
    Sugawara Y, Harihara Y, Takayama T, Makuuchi M. Suppression of cytokine production by thromboxane A2 inhibitor in liver ischemia. Hepatogastroenterology 1998; 45: 17811786.
  • 26
    Nagai H, Shimazawa T, Yakuo I, Aoki M, Kosa A, Kasahara M. The role of thromboxane A2 (TXA2) in liver injury in mice. Prostaglandins 1989; 38: 439446.
  • 27
    Kuhn DC, Stauffer JL, Gaydos LJ, Lacey SL, Demers LM. An inhibitor of thromboxane production attenuates tumor necrosis factor release by activated human alveolar macrophages. Prostaglandins 1993; 46: 195205.
  • 28
    Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer H-J, Mayer K, et al. Endotoxin-induced myocardial tumor necrosis factor-α synthesis depresses contractility of isolated rat hearts. Evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000; 102: 27582764.
  • 29
    Ishizuka T, Kawakami M, Hidaka T, Matsuki Y, Takamizawa M, Suzuki K, Kurita A, et al. Stimulation with thromboxane A2 (TXA2) receptor agonist enhances ICAM-1, VCAM-1 or ELAM-1 expression by human vascular endothelial cells. Clin Exp Immunol 1998; 112: 464470.
  • 30
    Sakamoto S, Okanoue T, Itoh Y, Nakagawa Y, Nakamura H, Morita A, Daimon Y, et al. Involvement of Kupffer cells in the interaction between neutrophils and sinusoidal endothelial cells in rats. Shock 2002; 18: 152157.
  • 31
    Neubauer K, Ritzel A, Saile B, Ramadori G. Decrease of platelet-endothelial cell adhesion molecule 1-gene-expression in inflammatory cells and in endothelial cells in the rat liver following CCl(4)-administration and in vitro after treatment with TNFalpha. Immunol Lett 2000; 74: 153164.
  • 32
    Essani NA, Fisher MA, Farhood A, Manning AM, Smith CW, Jaeschke H. Cytokine-induced upregulation of hepatic intercellular adhesion molecule-1 messenger RNA expression and its role in the pathophysiology of murine endotoxin shock and acute liver failure. HEPATOLOGY 1995; 21: 16321639.
  • 33
    Chosay JG, Fisher MA, Farhood A, Ready KA, Dunn CJ, Jaeschke H. Role of PECAM-1 (CD31) in neutrophil transmigration in murine models of liver and peritoneal inflammation. Am J Physiol 1998; 274: G776G782.
  • 34
    Rieder H, Ramadori G, Allmann K-H, Meyer K-H, Büschenfelde M. Prostanoid release of cultured liver sinusoidal endothelial cells in response to endotoxin and tumor necrosis factor. J Hepatol 1990; 11: 359366.
  • 35
    Mack Strong VE, Mackrell PJ, Concannon EM, Mestre JR, Smyth GP, Schaefer PA, Stapleton PP, et al. NS-398 treatment after trauma modifies NF-κB activation and improves survival. J Surg Res 2001; 98, 4046.
  • 36
    Leach M, Hamilton LC, Olbrich A, Wray GM, Thiemermann C. Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: a comparison with dexamethasone. Br J Pharmacol 1998; 124: 586592.
  • 37
    Doi F, Goya T, Torisu M. Potential role of hepatic macrophages in neutrophil-mediated liver injury in rats with sepsis. HEPATOLOGY 1993; 17: 10861094.
  • 38
    Shiratori Y, Tanaka M, Hai K, Kawase T, Shirna S, Sugimoto T. Role of endotoxin-responsive macrophages in hepatic injury. HEPATOLOGY 1990; 11: 183192.
  • 39
    Dahm LJ, Schultze AE, Roth RA. Activated neutrophils injure the isolated, perfused rat liver by an oxygen radical-dependent mechanism. Am J Pathol 1991; 139: 10091020.
  • 40
    Kurose I, Kato S, Ishii H, Fukumura D, Miura S, Suematsu M, Tsuchiya M. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. HEPATOLOGY 1993; 18: 380388.
  • 41
    Sakaguchi T, Nakamura S, Suzuki S, Oda T, Ichiyama A, Baba S, Okamoto T. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats. HEPATOLOGY 1999; 30: 959967.
  • 42
    Feder LS, Todaro JA, Laskin DL. Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J Leukocyte Biol 1993; 53: 126132.